Try Alerts Free   |   Login

Amag Pharmaceuticals Financials and Smart Investor 13F Alerts

AMAG Sector: Health Care, Pharmaceutical Preparations

Data imported from SEC filings and provided as-is without any warranty. Check Amag Pharmaceuticals Inc filings before making any investment decision.

AMAG stock chart compared to Revenue:
Get email alerts for new filings: We will never share your email address. By submitting your email, you agree to our Terms of Service and Privacy Policy.

AMAG Income Statement

Revenue, Net:52755000
Cost of Goods and Services Sold:18180000
Selling, General and Administrative Expense:39568000
Total Operating Expenses:59764000
Operating Income:-7009000
Income Taxes:-160000
Net Income (Loss) Attributable to Parent:-13244000
Earnings Per Share, Diluted:-0.39
Earnings Per Share, Basic:-0.39
Weighted Average Number of Shares Outstanding, Basic:34479646
Weighted Average Number of Shares Outstanding, Diluted:34353000

AMAG Cash Flow

Depreciation, Depletion and Amortization:9473000
Change in Accounts Receiveable:-41375000
Net Cash from Operations:3167000
Payments for Repurchase of Common Stock:0
Net Cash from Financing Activities:515000
Payments to Acquire Property, Plant, and Equipment:0
Net Cash from Investing Activities:40384000
Net Change in Cash and Cash Equivalents:44066000

AMAG Balance Sheet

Cash and Cash Equivalents:99016000
Accounts Receivable, Net:65104000
Total Current Assets:263557000
Property, Plant and Equipment, Net:3031000
Other Long-Term Assets:null
Total Assets:715549000
Accounts Payable:12944000
Current Portion of Long-Term Debt:0
Total Short-Term Liabilities:160999000
Long Term Debt, Non-Current Portion:285137000
Total Liabilities:466227000